Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for freezing of gait in Parkinson's disease
ACTRN12614000355673Phase 3Not yet recruiting
- Sponsor
- A/Prof Simon Lewis
- Start
- May 2014
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Rasagiline with Placebo (2 arms). Primary endpoint: Time spent frozen during Timed Up and Go. Planned start May 2014; status: not yet recruiting.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ACTRN12614000355673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000355673.